{"id":"W2062155368","doi":"10.1111/j.1365-2036.2009.04112.x","title":"Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease","year":2009,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"AstraZeneca; Pfizer","keywords":"Medicine; Certolizumab pegol; Inflammatory bowel disease; Adalimumab; Infliximab; Immunology; Context (archaeology); Viral hepatitis; Disease; Tumor necrosis factor alpha; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004804609,0.001043243,0.001617365,0.002696195,0.0003513425,0.001124085,0.0009117189,0.001361316,0.00485451],"category_scores_gemma":[0.001219322,0.0002411578,0.0004753584,0.00489823,0.0004428356,0.001795117,0.0005010167,0.001438268,0.002667225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006791286,"about_ca_system_score_gemma":0.001407363,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001237629,"about_ca_topic_score_gemma":0.001962504,"domain_scores_codex":[0.9997099,0.00006486267,0.00006416828,0.00004001431,0.00009559131,0.0000254517],"domain_scores_gemma":[0.999343,0.0002929538,0.0001174759,0.00001231766,0.0001703744,0.00006389448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001446083,0.00007779846,0.00055753,0.04210972,0.0001674223,0.0012483,0.0001454586,0.0003639876,0.001188716,0.001450916,0.1707885,0.7817571],"study_design_scores_gemma":[0.00004123991,0.0001057211,0.002410848,0.01180125,0.0001985638,0.009113603,0.0001423359,0.00008412395,0.0002485868,0.001038094,0.9747901,0.00002546702],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009925574,0.9977804,0.00004958362,0.0003537207,0.00101462,0.000004267843,0.00001534806,0.000004288247,0.0006784595],"genre_scores_gemma":[0.0006683057,0.9974061,0.0001277213,0.0003321168,0.0008603816,0.00000528384,0.00002998147,0.000001237666,0.0005689454],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00485451,"threshold_uncertainty_score":0.01623994,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02885084303652836,"score_gpt":0.3447917813239531,"score_spread":0.3159409382874247,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}